1 !! ! ! For Immediate Release By IAG HEALTHSCIENCES PTE. LTD. 15 Sept 2014 MEMORANDUM OF UNDERSTANDING TO COLLABORATE AND DEVELOP A CHINA-ASEAN TRADITIONAL CHINESE MEDICINAL PLATFORM Singapore’s IAG Healthsciences used as platform for international expansion while Beijing’s China National Medical Equipment Industry Corporation provides access to the key gateway cities of the People’s Republic !! ! ! !! ! of China. ANNOUNCEMENT Singapore – Sep 15, 2014 – The Management of IAG Healthsciences Pte Ltd (“IAG”) and Guangxi Botanical Garden of Medicinal Plants are pleased to announce that they have reached a Memorandum of Understanding to collaborate and jointly develop a China-Asean Traditional Chinese Medicinal platform. 1. The objective of the co-operation covers Research, identification and Qualification of Chinese medicinal botanics by chemical profiling to create a repository and distribution centre for reference-standard profiles of Chinese botanics modelled after the ATCC .Profiling will include the 4 established finger-printing methods in the western world, namely – HPLC/TLC, DNA, FarInfrared (FIR). 2. Establish IP protection of proprietary international legal frameworks. ! formularies through established 3. Commercialize the registered Chinese medicinal botanics and its derivative products (the “Products”) based on international quality standards and uniform set of regulations. 4. Research and development in the area of pain management for treatment of cancer, obstetrics, gynaecology and paediatrics etc. 。! The areas of this joint co-operation include: 1. Research and development in Traditional Chinese Medicines. 2. Aged care , healthcare and wellness. 3. Chinese medical and healthcare system 4. Trading ( local and international) of Traditional Chinese Medicines. ! This collaboration received the support of the Guangxi Health and Family Planning Commission, Guangxi Administration of TCM and the Guangxi Investment Promotion Agency who were present during the signing ceremony. 2 Guangxi Health and Family Planning Commission Director, Li Guojian elaborated that: Once we set up a China - ASEAN Centre oF Excellence For Traditional Chinese Medicine in Guangxi, we can then utilise Guangxi’s rich heritage in TCM clinical medicine, abundant TCM resources, aged care, longevity and other advantages coupled with Singapore technology, inFormation management and strong international trading links, to cooperate and jointly promote Chinese medicine research, intellectual property protection, and to assist in the certiFication oF TCM products to meet international standards thereby promoting the trading oF these products internationally. ! ProF. Miao Jianhu, Director oF Guangxi Botanical Garden oF Medicinal Plants extends his support by saying “Through this MOU, we hope to Further extend our collaboration in TCM medical research, applications oF TCM in healthcare and aged care, improve services in the TCM healthcare system, create more trade in TCM products both domestically and internationally. “ !! ! IAG’s Group Managing Director, Shen Lee says: “On back of the China-Singapore FTA signed on 28 Oct 2008 and this year’s 11th China-Asean Expo, we have gone ahead to embrace Guangxi as our preFerred gateway city into China owing to its proximity to the Asean bloc countries and its rich repository oF Chinese medicinal resources. I believe, with skilled human resources and investment capital, Guangxi will crystalize its value For Chinese pharmaceutical-grade botanics and scale it regionally.’ ”! ! Concurrent with the signing oF the Memorandum oF Understanding, IAG announce that it intends to partner with established Chinese organizations to Facilitate its ambitions in the Greater China area, and to address the needs oF the various stakeholders including sovereign governments, the private sector traditional or tribal medicine providers and market lead-steers who wish to open channels For a ChinaAsean platForm For Chinese pharmaceutical-grade botanics. 3 About Institute of Medicinal Plants The Guangxi Botanical Gardens of Medicinal Plants is a professional research institute dedicated to the collection, conservation, organization, preservation and education of medicinal plants and herbs. They are also involved in quality assurance and standards drafting for Chinese herbal medicine products. About IAG Healthsciences Pte Ltd IAG Healthsciences Pte Ltd is a leading manager, financier, and owner of healthcare assets; it is a privately held, limited liability corporation incorporated in the Republic of Singapore with its headquarter located at 290 Orchard Road #0711/12, Paragon Medical Suites, Singapore 238859. Since 1998, IAG Healthsciences offer quality and affordable complementary Chinese medicinal botanics and services and complements the Western treatment of illnesses with an additional, adjunctive form of evidence-based therapies that has a proven track record in Chinese history and culture. In 2012, IAG Healthsciences established a wholly-owned foreign enterprise in Shanghai to facilitate its corporate ambitions in the People’s Republic of China. ! Our principal activities include:Healthcare consulting and management services Ownership/licensing of modern complementary medicine clinic charters ! Manufacture, importand wholesaleof Chinese proprietary medicine For more information on IAG Healthsciences, please visit www.iag.com.sg For further information, please contact: Guangxi Botanical Garden of Medicinal Plants Danna HUANG Tel : +86 771 560 1290 Email : mailto:[email protected] IAG Healthsciences Pte Ltd LIM Yeow Chong, Corporate Services 290 Orchard Road #07-11/12 Paragon Medical Suites Singapore 238859 +65 6836 3637 Email : [email protected] The Straits Times, 16 September 2014, Tuesday, Singapore Zao Bao, 16 September 2014, Tuesday, Singapore
© Copyright 2024 ExpyDoc
